Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly

Archives of Internal Medicine

Volumn 156, Issue 2, 1996, Pages 205-208

  Honkanen, Pekka O ^a,b   Keistinen, Timo ^b   Kivelä, Sirkka Liisa ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

AGED; ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; FEMALE; FEVER; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION;

AGED; BACTERIAL VACCINES; FEMALE; FEVER; FINLAND; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; INCIDENCE; INFLUENZA VACCINES; MALE; PNEUMOCOCCAL INFECTIONS; SKIN DISEASES; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

EID: 0030029086     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.2.205     Document Type: Article

References (28)

1. Barker WH, Mullooly JP. Impact of epidemic type A influenza In a defined adult population. Am J Epidemiol 1980;112:798-813
2. Lipsky BA, Boyko EJ, Inui TS, Koepsell TD Risk factors for acquiring pneumococcal infections. Arch Intern Med. 1986;146:2179-2185
3. Jokinen C, Heiskanen L, Juvonen H, et al Incidence of community acquired pneumonia in the population of four municipalities in Eastern Finland. Am J Epidemiol. 1993;137:977-988.
4. Barker WH, Mullooly JP. Influenza vaccination of elderly persons, reduction in pneumonia and influenza hospitalizarions and deaths. JAMA. 1980;244.2547-2549.
5. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991;325:1453-1460.
6. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklmam RR. Pneumococcal polysaccharide vaccine efficacy an evaluation of current recommendations. JAMA. 1993;270:1826-1831.
7. The Immunization Practices Advisory Committee. Prevention and control of influenza MMWR Morb Mortal Wkly Rep. 1990:39 1-13
8. The Immunization Practices Advisory Committee. Pneumococcal polysaccharide vaccine. MMWR Morb Mortal Wkly Rep. 1989;38:64-76.
9. McBean AM, Babish JD, Prihoda R. The utilization of pneumococcal polysaccharide vaccine among elderly medicare beneficiaries, 1985 through 1988. Arch Intern Med. 1991;151:2009-2016.
10. Schmitz RJ, Schwartz AM. Medicare coverage, vaccine promotion and rates of influenza vaccination among the Medicare population: 1988-1991. In: Hannoun C, Kendal AP, Klenk HD, Ruben FL, eds. Options for the Control of Influenza II. Princeton, NJ: Excerpta Medica; 1993:115-122
11. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Himman AR. Immunization policies and vaccine coverage among adults. Ann Intern Med. 1988; 108.616-625.
12. Centers for Disease Control. Influenza vaccination coverage levels in selected sites - United States, 1989. MMWR Morb Mortal Wkly Rep. 1990;39.159-167.
13. Nicholson KG, Wiselka MJ, May A. Influenza vaccination of the elderly. perceptions and policies of general practitioners and outcome of the 1985-86 immunization programme in Trent, UK. Vaccine. 1987;5 302-306
14. Nicholson KG Immunisation against influenza among people aged over 65 living at home in Leicestershire during winter 1991-2. BMJ. 1993,306:974-976
15. Broome CV, Breiman RF Pneumococcal vaccine past, present, and future. N Engl J Med. 1991,21:1507-1508
16. Carlson AJ, Davidson WL, McLean AA, et al. Pneumococcal vaccine: dose, revaccination, and coadministration with influenza vaccine. Proc Soc Exp Biol Med. 1979,161.558-563.
17. DeStefano F, Goodman RA, Noble GR, McClary GD, Smith SJ, Broome CV. Simultaneous administration of influenza and pneumococcal vaccines. JAMA. 1982 247 2551-2554
18. Immunization Practices Advisory Committee. Pneumococcal polysacchande vaccine MMWR Morb Mortal Wkly Rep 1989,38:64-74
19. Fiebach NH. Viscoli CM Patient acceptance of influenza vaccination. Am J Med. 1991;91:393-400.
20. Nichol KL, Lofgren RP, Gapinski J. Influenza vaccination: knowledge, attitudes, and behavior among high-risk outpatients. Arch Intern Med. 1992;152: 106-110.
21. Margolis KL, Nichol KL, Poland GA, Pluhar RE Frequency of adverse reactions to influenza vaccine in the elderly. JAMA. 1990;264 1139-1141.
22. Palache AM, Beyer WEP, Sprenger MJW, et al. Antibody response after influenza immunization with various vaccine doses: a double-blind, placebocontrolled, multi-centre, dose-response study in elderly, nursing home residents and young volunteers. Vaccine. 1993,11 3-9.
23. Govaert TME, Dinant GJ, Aretz K, Masurel N, Sprenger MJW, Knottnerus JA Adverse reactions to influenza vaccine in elderly people: randomised double-blind placebo-controlled trial BMJ. 1993;307:988-990.
24. Fiumara NJ, Waterman GE. Statewide geriatric immunization program with polyvalent pneumococcal vaccine (Pneumovax). Curr Ther Res. 1979;25:185-192.
25. Pönka A, Leinonen M. Adverse reactions to polyvalent pneumococcal vaccine Scand J J Infect Dis. 1982;14:67-71.
26. Glezen PW. Serious morbidity and mortality associated with influenza epidemics Epidemiol Rev. 1982;4:25-44.
27. Macfarlane JT, Colville A, Guion A, Macfarlane RM, Rose DH Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet. 1993,341:511-514.
28. Roghmann KJ, Tabloski PA, Bentley DW, Schiffman G. Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment. J Gerontol. 1987;42.265-270